- Clinical Trials
- April 2025
- 60 Pages
Global
From €1065EUR$1,200USD£931GBP
€1332EUR$1,500USD£1,164GBP
- Report
- October 2025
- 183 Pages
Global
From €3148EUR$3,545USD£2,751GBP
€3497EUR$3,939USD£3,056GBP
- Report
- October 2025
- 199 Pages
Global
From €3148EUR$3,545USD£2,751GBP
€3497EUR$3,939USD£3,056GBP
- Report
- October 2025
- 194 Pages
Global
From €3148EUR$3,545USD£2,751GBP
€3497EUR$3,939USD£3,056GBP
- Report
- August 2025
- 186 Pages
Global
From €3148EUR$3,545USD£2,751GBP
€3497EUR$3,939USD£3,056GBP
- Report
- August 2025
- 189 Pages
Global
From €3148EUR$3,545USD£2,751GBP
€3497EUR$3,939USD£3,056GBP
- Report
- August 2025
- 189 Pages
Global
From €3148EUR$3,545USD£2,751GBP
€3497EUR$3,939USD£3,056GBP
- Report
- April 2025
- 200 Pages
Global
From €2211EUR$2,490USD£1,932GBP
- Report
- November 2025
Global
From €4351EUR$4,900USD£3,802GBP
- Report
- November 2025
Global
From €4351EUR$4,900USD£3,802GBP
- Report
- July 2025
Global
From €4351EUR$4,900USD£3,802GBP
- Report
- June 2025
Global
From €4351EUR$4,900USD£3,802GBP
- Report
- September 2025
- 250 Pages
Global
From €3987EUR$4,490USD£3,484GBP
- Report
- September 2025
- 250 Pages
Global
From €3987EUR$4,490USD£3,484GBP
- Report
- September 2025
- 250 Pages
Global
From €3987EUR$4,490USD£3,484GBP
- Report
- September 2025
- 250 Pages
Global
From €3987EUR$4,490USD£3,484GBP
- Report
- July 2025
- 175 Pages
Global
From €3987EUR$4,490USD£3,484GBP
- Report
- April 2025
- 250 Pages
Global
From €3987EUR$4,490USD£3,484GBP
- Report
- April 2025
- 200 Pages
Global
From €3987EUR$4,490USD£3,484GBP
- Report
- April 2025
- 200 Pages
Global
From €3987EUR$4,490USD£3,484GBP

Serotonin is a neurotransmitter found in the central nervous system (CNS) that plays a role in regulating mood, appetite, sleep, and other bodily functions. It is a key target for drugs used to treat depression, anxiety, and other mental health disorders. Serotonin-based drugs are typically selective serotonin reuptake inhibitors (SSRIs) or serotonin-norepinephrine reuptake inhibitors (SNRIs). These drugs work by blocking the reuptake of serotonin, allowing it to remain active in the brain for longer periods of time.
The serotonin market is a subset of the larger CNS drug market, which is estimated to be worth billions of dollars. It is a highly competitive market, with many large pharmaceutical companies vying for market share. Companies in the serotonin market include Eli Lilly, Pfizer, GlaxoSmithKline, AstraZeneca, and Bristol-Myers Squibb. Show Less Read more